Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 The Rise of Radiotherapeutics: Brief History and Best Practices for Clinical Trials By Rupa Doshi January 5, 2023 Featured Posts Clinical ResearchPhase 1 - Phase 4 Premier Perspective on Biomarkers in Oncology By Rupa Doshi November 2, 2022 Clinical ResearchPhase 1 - Phase 4 7 Factors Fueling the Growth of Oncology Trials in Asia-Pacific By Rupa Doshi August 15, 2022 Recent Posts By expertise area All expertise areas Digital TherapeuticsAnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnosticsReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Conducting Successful Oncology Trials in the Asia-Pacific Region By Rupa Doshi August 8, 2022 Clinical ResearchPhase 1 - Phase 4 The Role of Maintenance Therapy in Gynecologic Cancer Treatment By Rupa Doshi April 5, 2022 Clinical ResearchPhase 1 - Phase 4 Challenges and Opportunities in Gynecologic Cancer Research: Excerpts from a Round Table Discussion By Rupa Doshi March 29, 2022 Clinical ResearchPhase 1 - Phase 4 Choose the Right FDA Program to Expedite Your Rare Oncology Trial By Rupa Doshi December 2, 2020 Clinical ResearchPhase 1 - Phase 4 Adaptive Design Methods Offer Rapid, Seamless Transition Between Study Phases in Rare Cancer Trials By Rupa Doshi November 17, 2020 Clinical ResearchPhase 1 - Phase 4 Tumor-Agnostic Treatments: A Game Changer for Rare Oncology Trials By Rupa Doshi October 28, 2020 × ALSO OF INTERESTPremier Research Oncology Expertise
